Dr. Fernando L. Pagan

Dr. Scholz is a neurologist and geneticist specializing in neurodegenerative disorders such as Parkinson's disease, atypical parkinsonism and dementia syndromes. She received her medical degree from the Medical University Innsbruck, Austria. Following graduation, she was a postdoctoral fellow at the National Institutes of Health under the supervision of Drs. Andrew Singleton and John Hardy. She obtained a Ph.D. in neurogenomics from the University College London, UK in 2010. She then moved to Baltimore to complete her neurology residency training at Johns Hopkins. In 2015 Dr. Scholz received the McFarland Transition to Independence Award for Neurologist-Scientists. She is Lasker Clinical Research Scholar at the National Institute of Neurological Disorders and Stroke focusing on genetic causes of neurodegenerative syndromes, and an adjunct faculty member at Johns Hopkins' department of neurology. Dr. Scholz is rated as an Elite provider by MediFind in the treatment of Familial Dysautonomia. Her top areas of expertise are Lewy Body Dementia (LBD), Multiple System Atrophy, Movement Disorders, and Parkinson's Disease.

Dr. Pedro S. Buarque de Macedo is a neurologist affiliated with Sibley Memorial Hospital, as well as an assistant clinical professor of neurology at Georgetown University School of Medicine and an assistant clinical professor of physician assistant studies at George Washington University School of Medicine. He is also an adjunct assistant professor of clinical psychology at the Chicago School of Professional Psychology. He practices out of Washington Medical Group in Washington, D.C. Dr. Buarque de Macedo has an expertise in behavioral neurology, headaches, chronic pain, closed head injury and neurorehabilitation. Dr. Buarque de Macedo earned his undergraduate degree from Catholic University and his medical degree from the University of Maryland School of Medicine. He completed an internship in internal medicine at George Washington University Medical Center and a residency in neurology at Georgetown University and the Washington Veterans Administration Medical Center, where he served as chief resident. Dr. Buarque de Macedo is a member of the American Academy of Neurology and the American Headache Society. Dr. De Macedo is rated as an Advanced provider by MediFind in the treatment of Familial Dysautonomia. His top areas of expertise are Familial Dysautonomia, Migraine with Brainstem Aura, Cerebellar Degeneration, and Migraine.

Dr. Alexander Pantelyat cares for patients with movement disorders such as Parkinson's disease and related syndromes, essential tremor, dystonia, chorea and normal pressure hydrocephalus. He also provides botulinum toxin injections for movement disorders and is involved in deep brain stimulation programming and intraoperative neurophysiological monitoring.His research explores atypical parkinsonian disorders, such as dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome/degeneration and multiple system atrophy; cognitive aspects of movement disorders; and music-based rehabilitation of neurodegenerative diseases.Dr. Pantelyat earned his medical degree from Temple University School of Medicine in Philadelphia, where he was elected a member of the Alpha Omega Alpha Honor Medical Society and received the Matthew T. Moore Prize in Neurology. He completed his residency training in Neurology ​at the University of Pennsylvania in Philadelphia, and a fellowship in movement disorders at the University of Pennsylvania/Philadelphia VA Medical Center. As part of his fellowship, Dr. Pantelyat also completed the Clinical Research Certificate Program at the Center for Clinical Epidemiology and Biostatistics. He is a 2013 American Academy of Neurology Palatucci Advocacy Leader and grant recipient. Dr. Pantelyat is rated as an Elite provider by MediFind in the treatment of Familial Dysautonomia. His top areas of expertise are Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Corticobasal Degeneration.